MircroPort Medbot-B

02252

----

Current ValuationThe current P/E ratio is -79.03, below the reasonable range, cheaper than 88.97% of the time in the past 5 years, and the industry ranks 29/32, the industry Median 9.23.

-79.03xP/E

Stock priceHK$21.18Earnings per shareHK$-0.27

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

Industry median 9.23x

011223344

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

Industry median 9.23x

0x20x40x60x80x100x

P/E ratio
Name/Symbol
02252HKMircroPort Medbot-B	-79.03x	136.07%	HK$21.84B
02675HKEDGE MEDICAL-B	-494.81x	--	HK$10.70B
02526HKDIAGENS-B	-71.69x	--	HK$10.04B
09877HKJENSCARE-B	-15.54x	65.36%	HK$2.69B
09996HKPEIJIA-B	-16.51x	104.51%	HK$2.68B
02697HKTH MEDICAL-B	-16.29x	--	HK$1.76B
06669HKACOTEC-B	-30.05x	12.32%	HK$1.74B
02160HKMP CARDIOFLOW-B	-11.13x	94.95%	HK$1.63B
06922HKCRYOFOCUS-B	-14.69x	--	HK$497.97M
02500HKVENUS MEDTECH-B	-0.83x	100.95%	HK$443.22M
02216HKBRONCUS-B	-2.09x	--	HK$297.80M
02185HKBIOHEART-B	-2.77x	--	HK$240.98M
02297HKRAINMED-B	-3.07x	--	HK$236.83M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.